162 related articles for article (PubMed ID: 26970415)
1. Development and Validation of a Disease-Specific Questionnaire to Assess Patient-Reported Symptoms in Polycystic Liver Disease.
Neijenhuis MK; Gevers TJ; Hogan MC; Kamath PS; Wijnands TF; van den Ouweland RC; Edwards ME; Sloan JA; Kievit W; Drenth JP
Hepatology; 2016 Jul; 64(1):151-60. PubMed ID: 26970415
[TBL] [Abstract][Full Text] [Related]
2. Symptom relief and not cyst reduction determines treatment success in aspiration sclerotherapy of hepatic cysts.
Neijenhuis MK; Wijnands TFM; Kievit W; Ronot M; Gevers TJG; Drenth JPH
Eur Radiol; 2019 Jun; 29(6):3062-3068. PubMed ID: 30542749
[TBL] [Abstract][Full Text] [Related]
3. Expanding the clinical application of the polycystic liver disease questionnaire: determination of a clinical threshold to select patients for therapy.
Barten TRM; Staring CB; Hogan MC; Gevers TJG; Drenth JPH;
HPB (Oxford); 2023 Aug; 25(8):890-897. PubMed ID: 37095030
[TBL] [Abstract][Full Text] [Related]
4. Development and Validation of a Patient-Reported Outcome Measurement for Symptom Assessment in Cirrhotic Ascites.
Neijenhuis M; Gevers TJG; Atwell TD; Gunneson TJ; Schimek AC; Kievit W; Drenth JPH; Kamath PS
Am J Gastroenterol; 2018 Apr; 113(4):567-575. PubMed ID: 29557942
[TBL] [Abstract][Full Text] [Related]
5. Impact of liver volume on polycystic liver disease-related symptoms and quality of life.
Neijenhuis MK; Kievit W; Verheesen SM; D'Agnolo HM; Gevers TJ; Drenth JP
United European Gastroenterol J; 2018 Feb; 6(1):81-88. PubMed ID: 29435317
[TBL] [Abstract][Full Text] [Related]
6. Clinical validity of a disease-specific health status questionnaire: the peripheral artery questionnaire.
Hoeks SE; Smolderen KG; Scholte Op Reimer WJ; Verhagen HJ; Spertus JA; Poldermans D
J Vasc Surg; 2009 Feb; 49(2):371-7. PubMed ID: 19028064
[TBL] [Abstract][Full Text] [Related]
7. Clinical Correlates of Mass Effect in Autosomal Dominant Polycystic Kidney Disease.
Kim H; Park HC; Ryu H; Kim K; Kim HS; Oh KH; Yu SJ; Chung JW; Cho JY; Kim SH; Cheong HI; Lee K; Park JH; Pei Y; Hwang YH; Ahn C
PLoS One; 2015; 10(12):e0144526. PubMed ID: 26641645
[TBL] [Abstract][Full Text] [Related]
8. Measuring illness beliefs in patients with lower extremity injuries: reliability and validity of the Dutch version of the Somatic Pre-Occupation and Coping questionnaire (SPOC-NL).
Reininga IH; Brouwer S; Dijkstra A; Busse JW; Ebrahim S; Wendt KW; El Moumni M
Injury; 2015 Feb; 46(2):308-14. PubMed ID: 25441575
[TBL] [Abstract][Full Text] [Related]
9. Questionnaire PLD-complaint-specific assessment identifies need for therapy in polycystic liver disease: A multi-centric prospective study.
Billiet A; Temmerman F; Coudyzer W; Van den Ende N; Colle I; Francque S; De Maeght S; Janssens F; Orlent H; Sprengers D; Delwaide J; Decock S; De Vloo C; Moreno C; van Malenstein H; van der Merwe S; Verbeek J; Nevens F
United European Gastroenterol J; 2023 Sep; 11(7):633-641. PubMed ID: 37278135
[TBL] [Abstract][Full Text] [Related]
10. Which Questionnaire Should Be Used to Measure Quality-of-Life Utilities in Patients with Acute Leukemia? An Evaluation of the Validity and Interpretability of the EQ-5D-5L and Preference-Based Questionnaires Derived from the EORTC QLQ-C30.
van Dongen-Leunis A; Redekop WK; Uyl-de Groot CA
Value Health; 2016; 19(6):834-843. PubMed ID: 27712712
[TBL] [Abstract][Full Text] [Related]
11. Development and validity testing of the neuropathy total symptom score-6: questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy.
Bastyr EJ; Price KL; Bril V;
Clin Ther; 2005 Aug; 27(8):1278-94. PubMed ID: 16199253
[TBL] [Abstract][Full Text] [Related]
12. Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages?
Rutten-van Mölken MP; Oostenbrink JB; Tashkin DP; Burkhart D; Monz BU
Chest; 2006 Oct; 130(4):1117-28. PubMed ID: 17035446
[TBL] [Abstract][Full Text] [Related]
13. Everolimus does not further reduce polycystic liver volume when added to long acting octreotide: results from a randomized controlled trial.
Chrispijn M; Gevers TJ; Hol JC; Monshouwer R; Dekker HM; Drenth JP
J Hepatol; 2013 Jul; 59(1):153-9. PubMed ID: 23499726
[TBL] [Abstract][Full Text] [Related]
14. The Neck Bournemouth Questionnaire cross-cultural adaptation into Dutch and evaluation of its psychometric properties in a population with subacute and chronic whiplash associated disorders.
Schmitt MA; de Wijer A; van Genderen FR; van der Graaf Y; Helders PJ; van Meeteren NL
Spine (Phila Pa 1976); 2009 Nov; 34(23):2551-61. PubMed ID: 19927105
[TBL] [Abstract][Full Text] [Related]
15. Polycystic liver disease: Classification, diagnosis, treatment process, and clinical management.
Zhang ZY; Wang ZM; Huang Y
World J Hepatol; 2020 Mar; 12(3):72-83. PubMed ID: 32231761
[TBL] [Abstract][Full Text] [Related]
16. Polycystic liver disease: a critical appraisal of hepatic resection, cyst fenestration, and liver transplantation.
Schnelldorfer T; Torres VE; Zakaria S; Rosen CB; Nagorney DM
Ann Surg; 2009 Jul; 250(1):112-8. PubMed ID: 19561475
[TBL] [Abstract][Full Text] [Related]
17. Gastroparesis Cardinal Symptom Index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms.
Revicki DA; Rentz AM; Dubois D; Kahrilas P; Stanghellini V; Talley NJ; Tack J
Qual Life Res; 2004 May; 13(4):833-44. PubMed ID: 15129893
[TBL] [Abstract][Full Text] [Related]
18. Evaluating health-related quality of life in patients with polycystic liver disease and determining the impact of symptoms and liver volume.
Wijnands TF; Neijenhuis MK; Kievit W; Nevens F; Hogan MC; Torres VE; Gevers TJ; Drenth JP
Liver Int; 2014 Nov; 34(10):1578-83. PubMed ID: 24313956
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Polycystic Liver Disease: Impact on Patient-reported Symptom Severity and Health-related Quality of Life.
Duijzer R; Barten TRM; Staring CB; Drenth JPH; Gevers TJG
J Clin Gastroenterol; 2022 Oct; 56(9):731-739. PubMed ID: 35997709
[TBL] [Abstract][Full Text] [Related]
20. The validity of EQ-5D US preference weights in liver transplant candidates and recipients.
Russell RT; Feurer ID; Wisawatapnimit P; Pinson CW
Liver Transpl; 2009 Jan; 15(1):88-95. PubMed ID: 19109831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
